Servings per Container: 60
cagrilintide + tirzepatide The cagrilintide dosage with tirzepatide combination targets three pathways (GLP-1, GIP, and amylin) versus four with the retatrutide combination (GLP-1, GIP, glucagon, and amylin)
Three independent tests are on file for this product, showing 99.83% for lot PH-KO80-0309 reported May 2026, 99.597% for lot cs-k0801012 reported February 2026, and 99.68% for a lot reported November 2025
You deserve to feel recharged and confident, inside and out!
But calling these compounds 'treatments' for varicose veins means claiming efficacy that hasn't been demonstrated in controlled human trials
1800 mg/day, p.o., for 6 months